Speakers

Here’s a look at some of the participating companies from our previous speaking faculties:


Abbott Laboratories, Actelion Pharmaceuticals Ltd, Aerie Pharmaceuticals, Alcon Laboratories, Inc., Alder Biopharmaceuticals, Alexion Pharmaceuticals, Align Strategy, Allergan, Amgen, Amylin Pharmaceuticals, Inc., APP Pharmaceuticals, Aptalis Pharma, Astellas Pharma, AstraZeneca, Aurora WDC, Avanir Pharmaceuticals, AVEO Oncology, Babson College, Bausch+Lomb, Baxter Corporation, Bayer, Bayer Consumer Care, Bayer Consumer Health, Bayer HealthCare, Bayer Pharmaceuticals, Bayer Schering Pharma AG, BD Diagnostics – Preanalytical Systems, Best Practices, LLC, Biogen Idec, Biogenerics Australia, BioMedTracker, Biovail, Bioxcel Corportation, BizInt Solutions, Inc., Boehringer Ingelheim, Boston Scientific Corporation, Bristol-Myers Squibb, Cambridge Semantics, Celgene, Cempra, Citeline, Inc., Collegium Pharmaceuticals, Concert Pharmaceuticals, Conva Tec, Covance Inc., Covidien, CSL Behring, DARA Biosciences, Datamonitor, Deallus Consulting, Decision Resources Group, Defined Health, Dendreon, Denodo Technologies, Diaceutics, Digimind, Dolcera, Draftfcb HealthCare, DSM Pharmaceutical, Dun & Bradstreet, Edge Therapeutics, Eisai, Eli Lilly & Co., EMD Merck, EMD Serono, Endo Pharmaceuticals, Ensemble Discovery Corp., Ernst & Young, Ethicon, Evalueserve, Exelixis, Expert System, Fast Forward, Ferring Pharmaceuticals, FirstWord, Fletcher/CSI, LLC, Fuld + Company, Genentech, General Electric, Gen-Probe, Genzyme, GlaxoSmithKline, GlobalData, Harvard Medical School, Harvest Moon Pharmaceuticals, Helsinn Healthcare S.A., HHS, High Lantern Group, Hisun-Pfizer, ImClone Systems, Incyte Corporation, Indegene, Indigo Research, InfoNgen, Informa, INOVIS, Insmed, Intarcia, Intel Security, Ipsen Biopharmaceuticals, IQ 20/20, Irvine, Janssen, Johnson & Johnson Pharmaceutical Services, L.E.K. Consulting, Leerink Swann & Co, Lifescan, Lifescience Dynamics, Lundbeck, Lupin Pharmaceuticals, Mallinckrodt Pharmaceuticals, Marathon Pharmaceuticals, MEDRAD Corporate Innovations, Medtronic, Merck & Co, Inc., Merck Bioventures, Merial, Merrimack Pharmaceuticals, MetLife, Millennium Pharmaceuticals, MIT Center for Biomedical Innovation, Molekule Consulting, Morphotrust USA, National Pharmaceutical Council, Navigate International, NCI, Nerac, Nevakar, Nicox, Northern Light, Novartis Institutes for BioMedical Research, Novartis Pharma AG, NPS Pharmaceuticals, Ontoforce, Onyx Pharmaceuticals, Open Options, Oracle, ORC International, OSI Pharmaceutical, Otsuka America Pharmaceutical, Inc., Paragon Solutions, Patheon, Pfizer, Pfizer Consumer Healthcare, Pharma China, PharmARC Analytic Solutions, Philips Healthcare, Philips Medical Systems, Praetel, LLC, Preanalytical Systems, Prescient Healthcare Group, Proactive Worldwide, Purdue Pharma, RealEndpoints, Regeneron Pharmaceuticals, Richard Horowitz & Associates, Roche Diagnostics, Roche Laboratories, Roche/Genentech, Roger Green and Associates, Inc., Sandoz, Sanofi, Sanofi Pasteur, Santen Inc., Sarepta Therapeutics, SCIC, SciTech Strategies, Sedulo Group, ShiftCentral, Shire Human Genetic Therapies, Smith & Nephew, Snowfish, Soleil Securities Corp, Spectrum Pharmaceuticals, Springer, Stanford Group Companies, Takeda Pharmaceutical Company, TAP, Tasly, Teva, Teva Global Branded Products, The Dunn Group, The Larvol Group, The Takeda Oncology Company, Thermo Fisher Scientific, Thomson Reuters, University of Oxford, Upsher-Smith Laboratories, Veeva China, Versartis, Vertex Pharmaceuticals Inc, ViroPharma, Wolters Kluwer Health, World Federation of Chinese Medicine Societies, Xerox, ZIOPHARM Oncology, Zoetis, ZymoGenetics, Inc.